DocGo Inc. (NASDAQ:DCGO – Get Free Report) has received a consensus rating of “Hold” from the six brokerages that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $2.3750.
A number of research analysts have recently commented on DCGO shares. Wall Street Zen upgraded shares of DocGo from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Needham & Company LLC restated a “buy” rating and issued a $3.00 price target on shares of DocGo in a report on Tuesday, March 17th. Canaccord Genuity Group lowered their price objective on shares of DocGo from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Wednesday, March 25th. Cantor Fitzgerald restated an “overweight” rating on shares of DocGo in a research note on Monday, May 11th. Finally, Stifel Nicolaus reduced their target price on shares of DocGo from $4.00 to $2.50 and set a “buy” rating on the stock in a research report on Tuesday, March 17th.
Read Our Latest Analysis on DCGO
Institutional Inflows and Outflows
DocGo Stock Down 2.4%
NASDAQ DCGO opened at $0.57 on Thursday. The company has a fifty day moving average of $0.61 and a two-hundred day moving average of $0.73. The firm has a market capitalization of $55.91 million, a price-to-earnings ratio of -0.30 and a beta of 1.00. DocGo has a 52 week low of $0.49 and a 52 week high of $1.78.
DocGo (NASDAQ:DCGO – Get Free Report) last posted its quarterly earnings data on Monday, May 11th. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.10). The firm had revenue of $75.55 million for the quarter, compared to analysts’ expectations of $72.48 million. DocGo had a negative return on equity of 44.09% and a negative net margin of 62.23%. Equities research analysts anticipate that DocGo will post -0.12 EPS for the current year.
About DocGo
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
Featured Stories
- Five stocks we like better than DocGo
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
